Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Biota Pharmaceuticals, Inc.

Biota was an Australian antiviral drug development company listed on the Australian Stock Exchange (ASX:BTA).

In 1989 Biota discovered the drug Zanamivir, which acts as a neuraminidase inhibitor for the treatment and prevention of influenza. This drug is licensed to GlaxoSmithKline and marketed as Relenza.

In November 2012, Biota Holdings Limited merged with American company Nabi Biopharmaceuticals to form Biota Pharmaceuticals.

The combined company has its headquarters in the U.S. and is now listed on the NASDAQ under the abbreviated code BOTA.


Investment goal date:
Dividends reinvested
Biota Pharmaceuticals, Inc. BOTA report Q2 2016
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2016
2016-09-19
--
--
Q3 2016
2016-05-05
--
--
Q2 2016
2016-02-05
-0.1700
-0.1700
Q1 2016
2015-11-06
0.0000
-0.1700
Q4 2015
2015-09-11
0.0000
-0.5500
Q3 2015
2015-05-07
0.0000
0.0300
Q2 2015
2015-02-05
0.1900
0.1900
Q1 2015
2014-11-07
-0.2000
-0.2000
Q4 2014
2014-09-26
-0.2900
-0.2900
Q3 2014
2014-05-06
0.0900
0.0900
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Dominick & Dominick LLC
150166
Major Shareholders
Name Relationship
Total Shares
Holding stocks